Accustem Sciences (ACUT) EPS (Basic) Growth (1y) (2022 - 2026)
Accustem Sciences (ACUT) EPS (Basic) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | -16.29% |
| 10 | Accustem Sciences | 2.57 Mn | 2.56 Mn | - | 37.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.66% |
| Dec 31, 2025 | -3.77% |
| Sep 30, 2025 | 13.97% |
| Jun 30, 2025 | -1.85% |
| Mar 31, 2025 | 25.42% |
| Dec 31, 2024 | -50.06% |
| Sep 30, 2024 | 45.17% |
| Jun 30, 2024 | 25.36% |
| Mar 31, 2024 | 36.81% |
| Dec 31, 2023 | 75.59% |
| Sep 30, 2023 | 33.48% |
| Jun 30, 2023 | 65.46% |
| Mar 31, 2023 | 6.83% |
| Dec 31, 2022 | -63.43% |
| Sep 30, 2022 | -1,164.27% |
| Jun 30, 2022 | -1,781.74% |
| Mar 31, 2022 | -5,581.47% |